13 06, 2024 Comparison of Omicron breakthrough infection versus monovalent SARS-CoV-2 intramuscular booster reveals differences in mucosal and systemic humoral immunity Neal Evan Caminsky2024-06-13T11:49:58-04:00June 13, 2024|Funded Research Results, Pillar 1|
12 06, 2024 Dynamics of T-cell responses following COVID-19 mRNA vaccination and breakthrough infection in older adults Neal Evan Caminsky2024-06-12T14:42:37-04:00June 12, 2024|Funded Research Results, Pillar 1|
12 06, 2024 People with Human Immunodeficiency Virus receiving suppressive antiretroviral therapy show typical antibody durability after dual coronavirus disease 2019 vaccination and strong third dose responses Neal Evan Caminsky2024-06-12T12:21:42-04:00June 12, 2024|Funded Research Results, Pillar 1|
12 06, 2024 Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination Neal Evan Caminsky2024-06-12T11:32:15-04:00June 12, 2024|Funded Research Results, Pillar 1|
12 06, 2024 Antibody response durability following three-dose coronavirus disease 2019 vaccination in people with HIV receiving suppressive antiretroviral therapy Neal Evan Caminsky2024-06-13T10:23:35-04:00June 12, 2024|Funded Research Results, Pillar 1|
11 06, 2024 SARS-CoV-2 live virus neutralization after four COVID-19 doses in people with HIV receiving immunosuppressive antiretroviral therapy Neal Evan Caminsky2024-06-11T12:21:48-04:00June 11, 2024|Funded Research Results, Pillar 1|
27 09, 2023 Human-vision-inspired cluster identification for single-molecule localization microscopy Neal Evan Caminsky2023-09-27T14:09:54-04:00September 27, 2023|Funded Research Results, Pillar 1|
3 08, 2023 Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection Neal Evan Caminsky2023-08-03T14:57:57-04:00August 3, 2023|Funded Research Results, Pillar 1|
2 11, 2022 Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine but strong initial responses to a third dose Neal Evan Caminsky2022-11-15T09:12:42-05:00November 2, 2022|Funded Research Results, Pillar 1|
2 11, 2022 Impact of age and SARS-CoV-2 breakthrough infection on humoral immune responses after three doses of COVID-19 mRNA vaccine Neal Evan Caminsky2022-11-15T09:12:39-05:00November 2, 2022|Funded Research Results, Pillar 1|
